PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations

Jin Ho Kim, Doo Ho Choi, Dae Yeon Cho, Sei Hyun Ahn, Byung Ho Son, Bruce G. Haffty

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

PALB2 is a recently discovered breast cancer susceptibility gene, and mutations in the gene have been demonstrated to confer about twofold higher risk of breast cancer. Truncating mutations in PALB2 gene have been identified in varied populations. However, PALB2's significance to breast cancer has not been investigated in the Korean population. In this study, we evaluated the frequency of PALB2 1592delT and 229delT mutations in 300 Korean breast cancer patients diagnosed with either familial or early-onset breast cancer. All patients were confirmed negative for BRCA1 and BRCA2 mutations. Neither 1592delT nor 229delT mutations was found in any of the study cohort. Our results imply that these mutations are absent or rare in Korean patients who are negative for BRCA1 and BRCA2 mutations. We found no evidence to recommend screening for these mutations in the Korean population. However, PALB2 mutations have been demonstrated infrequent and inhomogeneous across investigated populations. Thus, screening the whole PALB2 gene for novel mutations is required to elucidate its significance in predisposition to breast cancer in Korean women.

Original languageEnglish (US)
Pages (from-to)303-306
Number of pages4
JournalBreast Cancer Research and Treatment
Volume122
Issue number1
DOIs
StatePublished - Jul 2010

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Keywords

  • Breast cancer
  • Korean
  • Mutation
  • PALB2
  • Susceptibility gene

Fingerprint Dive into the research topics of 'PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations'. Together they form a unique fingerprint.

Cite this